Catalyst
Pit
Terminal
Pit Consensus
Insiders
Politicians
Institutions
News
Screener
More ▾
Terminal
Pit Consensus
Insiders
Politicians
Institutions
News
Screener
More ▾
☰
ALNY
ALNYLAM PHARMACEUTICALS, INC.
NASDAQ · PHARMACEUTICAL PREPARATIONS
Last close
$219.89
· 2026-10-05
ABOUT
Exchange
NASDAQ
Sector
Healthcare
Industry
PHARMACEUTICAL PREPARATIONS
Market cap
$33.02B
Country
USA
RECENT INSIDER TRADES
2026-10-06
· SUPRAN BRYAN
(EVP, CLO and Secretary)
· SELL
2026-09-22
· Greenstreet Yvonne
(Chief Executive Officer)
· OTHER
2026-06-03
· PYOTT DAVID E I
(Director)
· OTHER
2026-06-03
· PYOTT DAVID E I
(Director)
· SELL
INSTITUTIONAL OWNERSHIP
Institutional holders
861
Shares held
216,707,203
Value
$46.52B
Percent of shares outstanding
161.95%
As of quarter end
2026-06-30
RECENT CONGRESSIONAL TRADES
2026-08-11
· Cory A Booker · SELL
· $1,001 - $15,000
2024-01-29
· Hon. Josh Gottheimer · SELL
· $1,001 - $15,000
2024-01-11
· Hon. Josh Gottheimer · BUY
· $1,001 - $15,000
2023-12-11
· Hon. Josh Gottheimer · SELL
· $1,001 - $15,000
RECENT NEWS
Alnylam Pharmaceuticals: More Than Meets The Eye After CARDIO-TTRansform
Alnylam Pharmaceuticals, Inc. Discusses Zilebesiran and the Potential of RNAi Therapeutics for Continuous Blood Pressure Control Transcript
Alnylam Pharmaceuticals, Inc. Discusses Zilebesiran and the Potential of RNAi Therapeutics for Continuous Blood Pressure Control - Slideshow
Alnylam Pharmaceuticals, Inc. (ALNY) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
Catalyst
Pit
Features
Coming soon
Pricing
Coming soon
Privacy
Terms
Disclaimer
Affiliate Terms
Contact
2026 CATALYSTPIT · NOT FINANCIAL ADVICE · DELAYED FILINGS